Search Results - "Svend, A"

Refine Results
  1. 1

    The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial by Mortensen, Svend A, Rosenfeldt, Franklin, Kumar, Adarsh, Dolliner, Peter, Filipiak, Krzysztof J, Pella, Daniel, Alehagen, Urban, Steurer, Günter, Littarru, Gian P

    Published in JACC. Heart failure (01-12-2014)
    “…This randomized controlled multicenter trial evaluated coenzyme Q10 (CoQ10) as adjunctive treatment in chronic heart failure (HF). CoQ10 is an essential…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    A Retrospective Evaluation of the Benefit of Referring Pediatric Cancer Patients to an External Proton Therapy Center by Munck af Rosenschold, Per, Engelholm, Svend A., Brodin, Patrik N., Jørgensen, Morten, Grosshans, David R., Zhu, Ronald X., Palmer, Matthew, Crawford, Cody N., Mahajan, Anita

    Published in Pediatric blood & cancer (01-02-2016)
    “…Background Pediatric cancer patients requiring radiation therapy (RT) have been routinely assessed and referred to proton therapy (PT) at an external…”
    Get full text
    Journal Article
  5. 5
  6. 6

    FDG PET/CT IMAGING IN CANINE CANCER PATIENTS by HANSEN, ANDERS E, MCEVOY, FINTAN, ENGELHOLM, SVEND A, LAW, IAN, KRISTENSEN, ANNEMARIE T

    Published in Veterinary radiology & ultrasound (01-03-2011)
    “…2-Deoxy-2-[¹⁸F]fluoro-d-glucose positron emission tomography/computed tomography (FDG PET/CT) is becoming increasingly available as an imaging modality in…”
    Get full text
    Journal Article
  7. 7

    The diagnostic value of PET/CT for primary ovarian cancer—A prospective study by Risum, Signe, Høgdall, Claus, Loft, Annika, Berthelsen, Anne K, Høgdall, Estrid, Nedergaard, Lotte, Lundvall, Lene, Engelholm, Svend A

    Published in Gynecologic oncology (01-04-2007)
    “…Abstract Objectives To prospectively evaluate the diagnostic value of combined PET/CT in detecting a malignant tumor in patients with no previous cancer…”
    Get full text
    Journal Article
  8. 8

    Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer by Risum, Signe, Loft, Annika, Høgdall, Claus, Berthelsen, Anne K, Høgdall, Estrid, Lundvall, Lene, Nedergaard, Lotte, Engelholm, Svend A

    Published in Acta oncologica (01-04-2011)
    “…In patients with advanced ovarian cancer undergoing preoperative PET/CT, we investigated the prognostic value of SUV in the primary tumor and we evaluated the…”
    Get more information
    Journal Article
  9. 9

    Health-related Quality of Life in Patients with Metastatic Spinal Cord Compression by Morgen, Søren S, Engelholm, Svend A, Larsen, Claus F, Søgaard, Rikke, Dahl, Benny

    Published in Orthopaedic surgery (01-08-2016)
    “…Objective Improvements in cancer treatment have resulted in an increased number of patients with metastatic spinal cord compression (MSCC). Because patients…”
    Get full text
    Journal Article
  10. 10

    Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass by Håkansson, Fanny, Høgdall, Estrid V S, Nedergaard, Lotte, Lundvall, Lene, Engelholm, Svend A, Pedersen, Anette T, Hartwell, Dorthe, Høgdall, Claus

    “…Risk of malignancy index (RMI), based on a serum cancer antigen 125 level, ultrasound findings and menopausal status, is used to discriminate ovarian cancer…”
    Get more information
    Journal Article
  11. 11

    Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma? by GRONLUND, Bo, HØGDALL, Claus, HILDEN, Jørgen, ENGELHOLM, Svend A, HØGDALL, Estrid V. S, HANSEN, Heine H

    Published in Journal of clinical oncology (15-10-2004)
    “…The aim of the study was to compare the prognostic value of a response by the Gynecologic Cancer Intergroup (GCIG) Cancer Antigen (CA) -125 response criteria…”
    Get full text
    Journal Article
  12. 12

    Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer by NEIJT, J. P, ENGELHOLM, S. A, TUXEN, M. K, SØRENSEN, P. G, HANSEN, M, SESSA, C, DE SWART, C. A. M, HIRSCH, F. R, LUND, B, VAN HOUWELINGEN, H. C

    Published in Journal of clinical oncology (17-09-2000)
    “…To determine the side effects and feasibility of cisplatin and carboplatin each in combination with paclitaxel as front-line therapy in advanced epithelial…”
    Get full text
    Journal Article
  13. 13

    Cerebral blood flow in patients with chronic heart failure before and after heart transplantation by GRUHN, Nicolai, LARSEN, Fin S, BOESGAARD, Siren, KNUDSEN, Gitte M, MORTENSEN, Svend A, THOMSEN, Gerda, ALDERSHVILE, Jan

    Published in Stroke (1970) (01-11-2001)
    “…Arterial blood pressure and cardiac output are often reduced in patients with chronic heart failure (CHF). Counterregulatory mechanisms with increased…”
    Get full text
    Journal Article
  14. 14

    Employment and sick leave in patients with prostate cancer before, during and after radiotherapy by Sveistrup, Joen, Mortensen, Ole S, Rosenschöld, Per M, Engelholm, Svend A, Petersen, Peter M

    Published in Scandinavian journal of urology (01-06-2016)
    “…The aim of this study was to determine employment outcomes after radiotherapy (RT) for prostate cancer (PCa). The Danish DREAM database contains information…”
    Get more information
    Journal Article
  15. 15

    A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer by Høgdall, Claus, Fung, Eric T, Christensen, Ib J, Nedergaard, Lotte, Engelholm, Svend A, Petri, Anette L, Risum, Signe, Lundvall, Lene, Yip, Christine, Pedersen, Anette T, Hartwell, Dorthe, Lomas, Lee, Høgdall, Estrid V.S

    Published in Gynecologic oncology (01-11-2011)
    “…Abstract Background Previous reports have shown that the proteomic markers apolipoprotein A1, hepcidin, transferrin, inter-alpha trypsin IV internal fragment,…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT by Hansen, Anders E., Kristensen, Annemarie T., Law, Ian, McEvoy, Fintan J., Kjær, Andreas, Engelholm, Svend A.

    Published in Radiotherapy and oncology (01-03-2012)
    “…To compare the distribution and uptake of the hypoxia tracer 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) (64Cu-ATSM) PET/CT, FDG PET/CT and dynamic contrast…”
    Get full text
    Journal Article
  20. 20